Completed NA INTERVENTIONAL 2-arm
NCT06472258
Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study
Sponsor: RESnTEC, Institute of Research
Conditions
Malaria
Interventions
IV Artesunate IV Quinine Hydrochloride
Updated 2 times since 2024 Last updated: Jun 24, 2024 Started: Mar 1, 2023 Primary completion: Jun 30, 2023 Completion: Jun 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Malaria, this trial is completed. The trial is conducted by RESnTEC, Institute of Research and has accumulated 2 data snapshots since 2023. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
2 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
First recorded
Mar 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- RESnTEC, Institute of Research
Data source: RESnTEC, Institute of Research
For direct contact, visit the study record on ClinicalTrials.gov .